Small molecule agents targeting the p53-MDM2 pathway for cancer therapy.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 6, p. 1159, doi. 10.1002/med.20236
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2012 AND VI 32 AND IP 6
Results: 7
1
2
Perspectives on medicinal properties of plumbagin and its analogs.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 6, p. 1131, doi. 10.1002/med.20235
- By:
- Publication type:
- Article
3
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 6, p. 1220, doi. 10.1002/med.20239
- By:
- Publication type:
- Article
4
Hydrogen sulphide: novel opportunity for drug discovery.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 6, p. 1093, doi. 10.1002/med.20234
- By:
- Publication type:
- Article
5
Oleoyl-Estrone.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 6, p. 1263, doi. 10.1002/med.20240
- By:
- Publication type:
- Article
6
Photodynamic therapy based on 5-aminolevulinic acid and its use as an antimicrobial Agent.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 6, p. 1292, doi. 10.1002/med.20251
- By:
- Publication type:
- Article
7
Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 6, p. 1197, doi. 10.1002/med.20237
- By:
- Publication type:
- Article